GaryW.ProcopMD

Pathology • Cleveland, OH

Microbiology, Anatomic Pathology, Clinical Pathology

Medical Director, Enterprise Laboratory Stewardship Committee Medical Director, Clinical Microbiology Cleveland Clinic

Join to view full profile

Dr. Procop is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Procop's full profile

Already have an account?

Office
9500 Euclid Avenue /LL2
Cleveland, OH 44195
Phone+1 216-444-5879

Education & Training

Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1996
Marshall University Joan C. Edwards School of MedicineClass of 1992

Certifications & Licensure

OH State Medical License 1998 - 2026
FL State Medical License 2006 - 2025
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Medical Microbiology

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients Start of enrollment: 2015 Jul 01
Terminated

Publications & Presentations

PubMed

134 citations
Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology.
John L. Frater, Gerri S. Hall, Gary W. Procop
Archives of Pathology & Laboratory Medicine. 2001-03-01
329 citations
Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection.
Robert Schlaberg, Charles Y. Chiu, Steve Miller, Gary W. Procop, George M. Weinstock
Archives of Pathology & Laboratory Medicine. 2017-02-07
69 citations
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.
Frank P Esper, Thamali M Adhikari, Zheng Jin Tu, Yu-Wei Cheng, Kim El-Haddad
The Journal of Infectious Diseases. 2023-02-01

Journal Articles

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)
Andres E Carmona-Rubio, Miriam Jacob, Gary W Procop, Mina K Chung, JAMA Cardiology

Authored Content

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020

Press Mentions

Lab Test Use: What 1 Billion Claims Tell UsAugust 3rd, 2024
Pathology Power List 2021: 75 HonoredAugust 18th, 2021
People Don’t Seem to Be as Interested in Testing for COVID Anymore — Why?April 21st, 2021
Join now to see all